Neurobiology of Aging
Volume 27, Issue 7 , Pages 933-940 , July 2006

Cognitive frailty: Predementia syndrome and vascular risk factors

  • Francesco Panza

      Affiliations

    • Department of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Bari, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 080 5473685; fax: +39 080 5478860.
    • ,
  • Alessia D’Introno

      Affiliations

    • Department of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Bari, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy
    • ,
  • Anna Maria Colacicco

      Affiliations

    • Department of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Bari, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy
    • ,
  • Cristiano Capurso

      Affiliations

    • Department of Geriatrics, University of Foggia, Foggia, Italy
    • ,
  • Angelo Del Parigi

      Affiliations

    • National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA
    • ,
  • Sabrina A. Capurso

      Affiliations

    • Department of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Bari, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy
    • ,
  • Richard J. Caselli

      Affiliations

    • Department of Neurology, Mayo Clinic, Scottsdale, AZ, USA
    • ,
  • Alberto Pilotto

      Affiliations

    • Department of Geriatrics, Casa Sollievo della Sofferenza, IRCCS, San Giovanni Rotondo, Foggia, Italy
    • ,
  • Emanuele Scafato

      Affiliations

    • National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità, Rome, Italy
    • ,
  • Antonio Capurso

      Affiliations

    • Department of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Bari, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy
    • ,
  • Vincenzo Solfrizzi

      Affiliations

    • Department of Geriatrics, Center for Aging Brain, Memory Unit, University of Bari, Bari, Policlinico, Piazza Giulio Cesare 11, 70124 Bari, Italy

Received 15 March 2005 ,Accepted 11 May 2005.

References 

  1. American Psychiatric Association Committee on Nomenclature Statistics. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. revised DSM-III-R. Washington, DC: American Psychiatric Association; 1987;
  2. American Psychiatric Association Committee on Nomenclature Statistics. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994;
  3. Bischkopf J, Busse A, Angermeyer MC. Mild cognitive impairment—a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand. 2002;106:403–414
  4. Blackford RC, La Rue A. Criteria for diagnosing age-associated memory impairment: proposed improvements from the field. Dev Neuropsychol. 1989;5:295–306
  5. Bozoki A, Giordani B, Heidebrink JL, Berent S, Foster NL. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol. 2001;58:411–416
  6. Brayne C, Calloway P. Normal aging, impaired cognitive function and senile dementia of Alzheimer type: a continuum?. Lancet. 1988;i:1265–1267
  7. Christensen H, Henderson AS, Jorm AF, Mackinnon AJ, Scott R, Korten AE. ICD-10 mild cognitive disorder: epidemiological evidence on its validity. Psychol Med. 1995;25:105–120
  8. Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Gershon S. Age associated memory impairment: proposed diagnostic criteria and measures of clinical change-report of a National Institute of Mental Health work group. Dev Neuropsychol. 1986;2:261–276
  9. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol. 2001;58:643–647
  10. DeCarli C, Mungas D, Harvey D, Reed B, Weiner M, Chui H, et al. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology. 2004;63:220–227
  11. Di Carlo A, Baldereschi M, Amaducci L, Maggi S, Grigoletto F, Scarlato G, et al. Cognitive impairment without dementia in older people: prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging. J Am Geriatr Soc. 2000;48:775–782
  12. D’Introno A, Panza F, Colacicco AM, Capurso A, Solfrizzi V. Mild cognitive impairment and related entities: role of vascular risk factors. In:  Panza F,  Solfrizzi V,  Capurso A editor. Diet and cognitive decline. NY, USA: Nova Science Publishers, Inc.; 2004;p. 1–33
  13. Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Neurology. 2000;54:1492–1497
  14. Ebly EM, Parhad FI.M. , Hogan DB, Fung TS. Prevalence and types of dementia in the very old: results from the Canadian Study of Health and Aging. Neurology. 1994;44:1593–1600
  15. Ebly EM, Hogan DB, Parhad IM. Cognitive impairment in the nondemented elderly: results from the Canadian Study of Health and Aging. Arch Neurol. 1995;52:612–619
  16. Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: predictors of dementia. Neurology. 1991;41:1006–1009
  17. Frisoni GB, Galluzzi S, Bresciani L, Zanetti O, Geroldi C. Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J Neurol. 2002;249:1423–1432
  18. Ganguli M, Dodge HH, Shen C, DeKosky ST. Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology. 2004;63:115–121
  19. Hanninen T, Hallikainen M, Koivisto K, Helkala EL, Reinikainen KJ, Soininen H, et al. A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J Am Geriatr Soc. 1995;43:1007–1015
  20. Henon H, Durieu I, Guerouaou D, Lebert F, Pasquier F, Leys D. Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology. 2001;57:1216–1222
  21. Jonker C, Schmand B, Lindeboom J, Havekes LM, Launer LJ. Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol. 1998;55:1065–1069
  22. Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and late-life mild cognitive impairment. A population-based study. Neurology. 2001;56:1683–1689
  23. Kivipelto M, Helkala EL, Laakso MP, Hanninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322:1447–1451
  24. Kuusisto J, Koivisto K, Mykkanen L, Helkala EL, Vanhanen M, Hanninen T, et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. BMJ. 1997;315:1045–1049
  25. Kral VA. Senescent forgetfulness: benign and malignant. Can Med Assoc J. 1962;86:257–260
  26. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, et al. Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology. 2002;59:1594–1599
  27. Larson EB. Illnesses causing dementia in the very elderly. N Engl J Med. 1993;328:203–205
  28. Levy R. Aging-associated cognitive decline. Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr. 1994;6:63–68
  29. Linn RT, Wolf PA, Bachman DL, Knoefel JE, Cobb JL, Belanger AJ, et al. The ‘preclinical phase’ of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch Neurol. 1995;52:485–490
  30. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, et al. Risk factors for mild cognitive impairment in the cardiovascular health study cognition study. Part 2. Arch Neurol. 2003;60:1394–1399
  31. Luis CA, Loewenstein DA, Acevedo A, Barker WW, Duara R. Mild cognitive impairment: directions for future research. Neurology. 2003;61:438–444
  32. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol. 2001;58:397–405
  33. Panza F, D’Introno A, Colacicco AM, Basile AM, Capurso C, Kehoe PG, et al. Vascular risk and genetics of sporadic late-onset Alzheimer's disease. J Neural Transm. 2004;111:69–89
  34. Panza F, Solfrizzi V, Colacicco AM, D’Introno A, Capurso C, Palasciano R, et al. Cerebrovascular disease in the elderly: lipoprotein metabolism and cognitive decline. Aging Clin Exp Res, in press.
  35. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid DJ, Thibodeau SN, et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA. 1995;273:1274–1278
  36. Petersen RC, Waring SC, Smith GE, Tangalos EG, Thibodeau SN. Predictive value of APOE genotyping in incipient Alzheimer's disease. Ann NY Acad Sci. 1996;802:58–69
  37. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangalos EG. Aging, memory, and mild cognitive impairment. Int Psychogeriatr. 1997;9(Suppl 1):65–69
  38. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308
  39. Petersen RC. Mild cognitive impairment: transition between aging and Alzheimer's disease. Neurologia. 2000;15:93–101
  40. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive decline. Arch Neurol. 2001;58:1985–1992
  41. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982;139:1136–1139
  42. Riley KP, Snowdon DA, Markesbery WR. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol. 2002;51:567–577
  43. Romas SN, Tang MX, Berglund L, Mayeux R. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology. 1999;53:517–521
  44. Schneider JA, Wilson RS, Bienias JL, Evans DA, Bennett DA. Cerebral infarctions and the likelihood of dementia from Alzheimer disease pathology. Neurology. 2004;62:1148–1155
  45. Small BJ, Basun H, Backman L. Three-year changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia. Psychol Aging. 1998;13:80–87
  46. Smith GE, Petersen RC, Parisi JE, Ivnik RJ, Kokmem E, Tangalos EG, et al. Definition, course, and outcome of mild cognitive impairment. Aging, Neuropsychol Cognit. 1996;3:141–147
  47. Solfrizzi V, Panza F, Torres F, Mastroianni F, Del Parigi A, Venezia A, et al. High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology. 1999;52:1524–1530
  48. Solfrizzi V, Panza F, D’Introno A, Colacicco AM, Capurso C, Basile AM, et al. Lipoprotein[a), apolipoprotein E genotype, and risk of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002;72:732–736
  49. Solfrizzi V, Panza F, Capurso A. The role of diet in cognitive decline. J Neural Transm. 2003;110:95–110
  50. Solfrizzi V, Panza F, Colacicco AM, D’Introno A, Capurso C, Torres F, et al. for the Italian Longitudinal Study on Aging Working Group. Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004;63:1882–1891
  51. Srikanth VK, Anderson JF, Donnan GA, Saling MM, Didus E, Alpitsis R, et al. Progressive dementia after first-ever stroke. A community-based follow-up study. Neurology. 2004;63:785–792
  52. Tervo S, Kivipelto M, Hanninen T, Vanhanen M, Hallikainen M, Mannermaa A, et al. Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord. 2004;17:196–203
  53. Traykov L, Rigaud AS, Baudic S, Smagghe A, Boller F, Forette F. Apolipoprotein E epsilon 4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease. J Neurol Sci. 2002;203/204:177–181
  54. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348:1215–1222
  55. Wolf H, Ecke GM, Bettin S, Dietrich J, Gertz HJ. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry. 2000;15:803–812
  56. World Health Organization. International statistical classification of diseases and related health problems, 10th revision (ICD-10). Chapter V, categories F00-F99. Mental, behavioural, and developmental disorders, clinical description and diagnostic guidelines. Geneva: World health Organization, 1992.
  57. Zaudig M. A new systematic method of measurement an diagnosis of “mild cognitive impairment” and dementia according to ICD-10 and DSM-III-R criteria. Int Psychogeriatr. 1992;(Suppl 2):203–219

PII: S0197-4580(05)00144-2

doi: 10.1016/j.neurobiolaging.2005.05.008

Neurobiology of Aging
Volume 27, Issue 7 , Pages 933-940 , July 2006

Article Tools